Our recent study on the use of dipstrips was limited to laboratory use, as noted by Mr Chessum and Dr Holliman, because factors outside the laboratory are more difficult to quantify in terms of cost and time, while also being outside our direct control. The reduction in laboratory workload and costs alone suggested by both letters may be offset by increased workload in other hospital departments and general practitioners' surgeries. For example, the cost, ordering, and invoicing of dispsticks, and nursing or medical time in performing and recording results should be taken into account. Routine transport costs are unlikely to be changed greatly as collections from clinical areas occur whether eight or 10 samples are taken to the laboratory. Whether Biopsy specimen length is important especially when it comes to assessing patterns of disease distribution. In our series the mean biopsy specimen length was 25 mm. In 25 of 52 patients with focal deposition of lymphoma there was a mixed distribution in a paratrabecular and nodular pattern (table 2) . Similarly, when diffuse disease was recorded it was sometimes present only in part of the biopsy specimen. The series of Juneja et al also recognises more than one pattern of infiltration. We find it difficult to comment at present on whether any particular type of infiltration is absolutely characteristic of any grade of lymphoma let alone subtype. We suggest that both nodular, non-paratrabecular infiltration, and paratrabecular infiltration are both variants of focal disease; they may well represent similar mechanisms of infiltration.
We agree with the comments made by the authors on bone marrow aspiration and peripheral blood and that when the appearances of marrow biopsy specimens are normal it is extremely rare to find positive peripheral blood or marrow aspirate samples.
The suggestion in the Juneja series that DLC is a special case which might benefit from bilateral biopsy requires further evaluation on large numbers of patients. We are currently undertaking such studies using single biopsy specimens in our own department and intend to publish these in due course. It would then be interesting to make further comparisons. By examining bilateral biopsy specimens we have found the incidence of bone marrow disease in non-Hodgkin's lymphoma to be 38%. We estimate that this has resulted in an increase in positivity rate over unilateral biopsy specimens of 15% overall and 25% in cases of diffuse large cell lymphoma. This is comparable with an increase of 10-22% reported in the previous two major series.'2 Roath et al have achieved a comparable incidence of 35% overall in their series using unilateral biopsy specimens. Possible reasons for this discrepancy could be the longer trephine in their series (25 mm compared with 19 mm in ours) and routine examination of three levels of the bone marrow biopsy specimen). Our practice is not to examine multiple levels except in cases with equivocal disease on the first level. It would be helpful if Roath et al would indicate how many cases would have been labelled negative by examining only one and not three levels.
Whether the number of cases of various histological subtypes differed in the two series and contributed to this discrepancy is difficult to ascertain because Roath et al have not mentioned these in their paper. On the basis of their data the use of bilateral biopsy specimens may not be justified if cores 2 mm or longer are obtained and these are examined at multiple levels. In fact, we make a similar point in our paper: "a question that remains unresolved is whether taking two biopsy specimens from the one side would achieve the same result with less discomfort for the patient." We are examining our own data to see if there is any correlation between marrow disease and the length of the biopsy specimen.
We agree with the findings of Roath et al regarding the occurrence of more than one pattern of marrow disease in many lymphomas and the fact that paratrabecular disease may occur with a focal, nonparatrabecular pattern. With regard to correlation with histology, our data seem to indicate that the paratrabecular pattern is characteristic of follicular lymphoma. In our study the interstitial pattern of disease was also not seen in any case of follicular lymphoma. Of course the possibility of discordant histology has to be bome in mind. The latter was seen in six cases of diffuse large cell lymphoma (DLCL) in our series whereby the lymph node biopsy specimen showed large cell lymphoma and the bone marrow biopsy specimen showed paratrabecular aggregates of small lymphoid cells. The stated aim of this textbook is to combine classic histological approaches to endocrine pathology with recent developments in immunohistochemistry and molecular biology. In attempting to achieve this aim in a single author textbook, covering the breadth of the endocrine system, Dr Lloyd has set himself a formidable task. He admits that certain areas have not been covered.
The text is variable. For example, there is a useful short, but comprehensive, discussion of the new classification of pituitary adenomas, based on immunohistochemistry and electron microscopy. In contrast, the problematic area of diagnosing malignancy in adrenocortical tumours is incompletely discussed and referenced. The book is extensively illustrated. There are very elegant colour plates of immunocytochemistry and non-isotopic in situ hybridisation, but some of the black and white photomicrographs are not as crisp as might be expected.
This volume must be compared with others based on a functional approach to the subject, which incorporate more of the clinical and biochemical aspects of endocrine disease. Perhaps to a greater extent than in any other area of pathology, histological diagnosis cannot stand alone. I feel, therefore, that this textbook will not be seriously competitive.
AM 
